Back to search

Peptide record

TPDB40616

14G Anticancer standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB40616
14G
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 23-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
ALWKSILKNAGKAGLNEINQIVQ-NH2
Physicochemical Analysis
C113H190N32O32
RDCHMFPTY
ANILK
2508.95
10.32
3
1
11
+2
2.66
-0.030
127.39
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
5500
219.22
6
Residue Composition
number
3
A
0
R
3
N
0
D
0
C
1
E
2
Q
2
G
0
H
3
I
3
L
3
K
0
M
0
F
0
P
1
S
0
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 3 D: 0 C: 0 E: 1 Q: 2 G: 2 H: 0 I: 3 L: 3 K: 3 M: 0 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 1
Chemical Descriptors
23
C113H190N32O32
2508.95
10.32
+2
2.66
-0.030
Amidation
L
Linear
Free
Antimicrobial and Anticancer
Dermaseptin-SS1- Analog
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 48.7 µM
Anticancer
48.7 µM

Target

Lung Cancer
H-838
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 31.7 µM
Anticancer
31.7 µM

Target

Lung Cancer
H-460
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023